Specify a stock or a cryptocurrency in the search bar to get a summary
CAMP4 THERAPEUTICS CORPORATION
CAMPCamp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: One Kendall Square Building 1400 West, Cambridge, MA, United States, 02139
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CAMP
Dividend Analytics CAMP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CAMP
Stock Valuation CAMP
Financials CAMP
Results | 2019 | Dynamics |